Lv32
388 积分 2024-07-19 加入
SLC3A2 Drives an Immunosuppressive Metabolic Axis that Limits Oncolytic Virotherapy Efficacy
1天前
已完结
Hypothesis-generating evaluation of multi-armoured oncolytic HSV-1 (VG161) in intrahepatic cholangiocarcinoma: pooled insights from multicentre studies
5个月前
已完结
PerC B‐Cells Activation via Thermogenetics‐Based CXCL12 Generator for Intraperitoneal Immunity Against Metastatic Disseminated Tumor Cells
8个月前
已完结
Spatially Controlled Co‐Delivery of Diagnostic and Therapeutic Agents Using DNA Nanoframeworks for Pancreatic Cancer Precision Therapy
8个月前
已完结
Antibody-drug conjugates: Current challenges and innovative solutions for precision cancer therapy
9个月前
已完结
Oncolytic Viruses in Cancer Treatment
10个月前
已完结
Oncolytic Viruses in Lung Cancer Treatment: A Review Article
10个月前
已关闭
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab
10个月前
已完结
Meeting the Unmet Needs in Rare Cancer
11个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1年前
已完结
皖公网安备34019202002308
